Document is current
Any future updates will be listed below
-
Authors
Hampel, Harald
Lista, Simone
Vanmechelen, Eugeen
Zetterberg, Henrik
Giorgi, Filippo Sean
Galgani, Alessandro
Blennow, Kaj
Caraci, Filippo
Das, Brati
Yan, Riqiang
Vergallo, Andrea http://orcid.org/0000-0002-0208-6384
,
Afshar, Mohammad
Aguilar, Lisi Flores
Akman-Anderson, Leyla
Arenas, Joaquín
Ávila, Jesús
Babiloni, Claudio
Baldacci, Filippo
Batrla, Richard
Benda, Norbert
Black, Keith L.
Bokde, Arun L. W.
Bonuccelli, Ubaldo
Broich, Karl
Cacciola, Francesco
Caraci, Filippo
Caruso, Giuseppe
Castrillo, Juan
Cavedo, Enrica
Ceravolo, Roberto
Chiesa, Patrizia A.
Corbo, Massimo
Corvol, Jean-Christophe
Cuello, Augusto Claudio
Cummings, Jeffrey L.
Depypere, Herman
Dubois, Bruno
Duggento, Andrea
Emanuele, Enzo
Escott-Price, Valentina
Federoff, Howard
Ferretti, Maria Teresa
Fiandaca, Massimo
Frank, Richard A.
Garaci, Francesco
Geerts, Hugo
Giacobini, Ezio
Giorgi, Filippo S.
Goetzl, Edward J.
Graziani, Manuela
Haberkamp, Marion
Habert, Marie-Odile
Hänisch, Britta
Hampel, Harald
Herholz, Karl
Hernandez, Felix
Imbimbo, Bruno P.
Kapogiannis, Dimitrios
Karran, Eric
Kiddle, Steven J.
Kim, Seung H.
Koronyo, Yosef
Koronyo-Hamaoui, Maya
Langevin, Todd
Lehéricy, Stéphane
Lemercier, Pablo
Lista, Simone
Llavero, Francisco
Lorenceau, Jean
Lucía, Alejandro
Mango, Dalila
Mapstone, Mark
Neri, Christian
Nisticò, Robert
O’Bryant, Sid E.
Palermo, Giovanni
Perry, George
Ritchie, Craig
Rossi, Simone
Saidi, Amira
Santarnecchi, Emiliano
Schneider, Lon S.
Sporns, Olaf
Toschi, Nicola
Valenzuela, Pedro L.
Vellas, Bruno
Verdooner, Steven R.
Vergallo, Andrea
Villain, Nicolas
Virecoulon Giudici, Kelly
Watling, Mark
Welikovitch, Lindsay A.
Woodcock, Janet
Younesi, Erfan
Zugaza, José L.
- License Information
-
More Information
Article History
Received: 8 June 2020
Accepted: 15 September 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: HH is an employee of Eisai Inc. This work has been performed during his previous position at Sorbonne University, Paris, France. At Sorbonne University, he was supported by the AXA Research Fund, the “Fondation partenariale Sorbonne Université,” and the “Fondation pour la Recherche sur Alzheimer,” Paris, France. HH serves as Senior Associate Editor for the journal <i>Alzheimer’s & Dementia</i> and does not receive any fees or honoraria since May 2019; before May 2019, he had received lecture fees from Servier, Biogen, and Roche; research grants from Pfizer, Avid, and MSD Avenir (paid to the institution); travel funding from Eisai, Functional Neuromodulation, Axovant, Eli Lilly and company, Takeda and Zinfandel, GE Healthcare, and Oryzon Genomics; and consultancy fees from Qynapse, Jung Diagnostics, Cytox Ltd., Axovant, Anavex, Takeda and Zinfandel, GE Healthcare, Oryzon Genomics, and Functional Neuromodulation; and participated in scientific advisory boards of Functional Neuromodulation, Axovant, Eisai, Eli Lilly and company, Cytox Ltd., GE Healthcare, Takeda and Zinfandel, Oryzon Genomics, and Roche Diagnostics.He is a co-inventor in the following patents as a scientific expert and has received no royalties:• In Vitro Multiparameter Determination Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Patent Number: 8916388.• In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases Patent Number: 8298784.• Neurodegenerative Markers for Psychiatric Conditions Publication Number: 20120196300.• In Vitro Multiparameter Determination Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Publication Number: 20100062463.• In Vitro Method for The Diagnosis and Early Diagnosis of Neurodegenerative Disorders Publication Number: 20100035286.• In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases Publication Number: 20090263822.• In Vitro Method for The Diagnosis of Neurodegenerative Diseases Patent Number: 7547553.• CSF Diagnostic in Vitro Method for Diagnosis of Dementias and Neuroinflammatory Diseases Publication Number: 20080206797.• In Vitro Method for The Diagnosis of Neurodegenerative Diseases Publication Number: 20080199966.• Neurodegenerative Markers for Psychiatric Conditions Publication Number: 20080131921.SL received lecture honoraria from Roche and Servier.AV is an employee of Eisai Inc. This work has been performed during his previous position at Sorbonne University, Paris, France. He does not receive any fees or honoraria since November 2019. Before November 2019, he had received lecture honoraria from Roche, MagQu LLC, and Servier.HZ has served at scientific advisory boards for Roche Diagnostics, Denali, Wave, Samumed, and CogRx; has given lectures in symposia sponsored by Alzecure and Biogen; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg.KB has served as a consultant or at advisory boards for Abcam, Axon, Biogen, Lilly, MagQu, Novartis, and Roche Diagnostics and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg, all unrelated to the work presented in this paper.ADV, FSG, AG, FC, BD, and YR report no biomedical financial interests or potential conflicts of interest.
